The Vascular Imaging Devices Market is projected to reach USD 11.12 billion by 2030, growing at a CAGR of 5.45% from USD 8.12 billion in 2023, DelveInsight

Vascular Imaging Devices Market Size, Forecast, Companies

<ul>
<li class="MsoNormal">The Vascular Imaging Market is expected to expand at a healthy growth rate during the forecast period (2024-2030), owing to the launch of new therapies, as per DelveInsight</li>
<li class="MsoNormal">The leading Vascular Imaging Companies such as Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TRUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.</li>
</ul>
Request for Unlocking the Sample Page of the &ldquo;<a href="https://www.delveinsight.com/sample-request/vascular-imaging-market-market">Vascular Imaging Market</a>&rdquo;
<a title="Vascular Imaging Devices Market" href="https://www.delveinsight.com/sample-request/vascular-imaging-market-market"><img src="https://assets.delveinsight.com/delveinsight-meta-images/vascular-imaging-market1.png" alt="Vascular Imaging Devices Market" width="800" height="420"></a>
Vascular Imaging Devices Market By Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, and Duplex Ultrasound), Application (Diagnostics and Therapeutics), End-User (Hospitals, Diagnostic Imaging Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of Vascular-Related Diseases.
The global Vascular Imaging Devices Market was valued at USD 8.12 billion in 2023, growing at a CAGR of 5.45% during the forecast period from 2024 to 2030, to reach USD 11.12 billion by 2030. The demand for Vascular Imaging Devices is primarily motivated by the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, Additionally,&nbsp;Vascular Imaging Devices were found to be extremely beneficial in <a href="https://www.delveinsight.com/report-store/covid-19-pipeline-insight">COVID-19</a> cases in the pandemic situation, which further pushed for the demand of these devices. Moreover, technological advancements and requirements of these devices for proper surgical planning and long-term disease management will eventually boost Market growth. The fact that Vascular Imaging is usually a non-invasive procedure is also escalating the growth of the Market.
<h2>Vascular Imaging Devices Market Dynamics</h2>
Vascular Imaging Devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension is responsible for driving the growth of the Vascular Imaging Devices Market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy. Based on data from NHANES (National Health and Nutrition Examination Survey; 2013&ndash;2016), an estimated 26 million adults have been diagnosed with <a href="https://www.delveinsight.com/report-store/diabetes-market">Diabetes</a>, 9.4 million adults (3.7%) have undiagnosed diabetes, and 91.8 million adults (37.6%) have prediabetes.
As per American Heart Association, 2021, the incidence of end-stage kidney disease in the United States is projected to increase from 11% to 18% by 2030. This will eventually lead to more prevalence of renal diseases and it will further boost the Global Vascular Imaging Devices Market growth.&nbsp;With the outbreak of COVID-19, almost all the countries were affected. Currently, numerous countries have started to improve their healthcare systems. Hence, as a preventive measure, governments across the world have started building new hospitals and diagnostic centers, where vascular imaging is kept as the utmost priority. Henceforth, it requires Vascular Imaging Devices, such as Ultrasound and CT, and <a href="https://www.delveinsight.com/report-store/magnetic-resonance-imaging-devices-market">MRI machines</a>.
Screening at home is critical in stopping the virulent spread of the virus. According to a paper published by the Chinese Center for Disease Control and Prevention, in February 2020, only 19% of patients who contracted COVID-19 had conditions severe enough to require hospitalization. The effect on the other 81% was mild enough for them to recover safely at home. This 19% will require the use of ultrasound imaging of both their lungs, which will substantially promote the Market for Vascular Imaging Devices. Thus, all these factors are projected to drive the growth of the Market for Vascular Imaging Devices.
Certain factors such as the very high cost of the equipment and the requirement of skilled and trained professionals for operating, pose a major hurdle to the growth of the Vascular Imaging Devices Market
<h2>Vascular Imaging Devices Market Segment Analysis:</h2>
Vascular Imaging Devices by Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound), Application (Diagnostics and Therapeutics), End-User (Hospitals, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Vascular Imaging Devices Market type segment, non-invasive devices are expected to hold the largest share in the Market as it is an important tool in the clinical assessment of patients, with a variety of vascular-related conditions. It allows the detection of changes in blood flow and rhythm, and it is essential in the detection of life-threatening arrhythmias. There are various types of non-invasive devices available in the Vascular Imaging Devices Market, such as Abdominal Ultrasound, Angiography, Captopril Renal Scan, MRA, MRI, Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound, among others.
The Vascular Imaging Devices Market is driven by factors such as the increase in the prevalence of heart disease, like stroke, and a growing aging population who are very susceptible to coronary heart disease, technological developments in&nbsp;Vascular Imaging Devices that minimize the chances of further infection, and improved efficiency of devices. In August 2021, The US Food and Drug Administration (FDA) cleared Abbott's latest <a href="https://www.delveinsight.com/report-store/optical-coherence-tomography-oct-devices-market">optical coherence tomography</a> (OCT) imaging platform powered by the company's new Ultreon Software. It combines OCT with artificial intelligence (AI) to provide physicians with an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making in the cath lab and provide the best pathway for treatment.
Additionally, assistance from government bodies, in equipping new/existing hospitals and healthcare centers in rural regions, is expected to enhance the Market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.
North America is expected to dominate the overall Vascular Imaging Devices Market
North America is expected to dominate the overall Vascular Imaging Devices Market during the forecast period. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the Global Vascular Imaging Devices Market growth.
Further, In the United States, according to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 6.5 million people aged 40 and older have PAD, which in turn, will increase the demand for Vascular Imaging Devices. This situation is giving rise to a critical need for Vascular Imaging Devices for the diagnosis, prevention, and treatment of the disease.
Europe and the Asia-Pacific region have the future potential for growth for global Vascular Imaging Devices. This is because many key Vascular Imaging Devices Companies are now available in these regions. In all countries, vascular-related illness rates have been increasing. Several reports have been released annually, mentioning that significant portions of the population in the European Union and the United States (including in the developed&nbsp;Market) suffer through more than one chronic disorder, such as hypertension, arrhythmias, diabetes, for a prolonged period, thus there is an enormous potential for Vascular Imaging Devices Market growth.
<h2>Vascular Imaging Devices Companies</h2>
The leading Vascular Imaging Devices Companies such as Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TRUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.
<h3>Recent Developmental Activities in The Vascular Imaging Devices Market</h3>
<ul>
<li>In August 2021, Abbott Laboratories received the US Food and Drug Administration (FDA) go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is first-of-its-kind imaging software that combines OCT with artificial intelligence (AI). The United States&rsquo; clearance for the OCT imaging platform closely follows the attainment of the CE Mark for the same in Europe.</li>
<li>In August 2021, Pulse Medical Imaging Technology (Shanghai) Co. Ltd. raised more than USD 100 million in a Series C funding round to accelerate the R&amp;D, clinical trials, and commercialization of its products. Pulse plans to use the funds to accelerate the commercialization of its fractional flow reserve (FFR) estimating systems. FFR is a method to measure blood pressure and flow within a coronary artery to check on the possibility that the stenosis impedes oxygen delivery to the heart muscle.</li>
<li>In August 2021, Trivitron has recently launched SonoRad V60 Ultrasound, devoted to delivering excellent imaging systems and exceptional image quality.</li>
</ul>
<h3>Key Takeaways from the Vascular Imaging Devices Market Report Study</h3>
<ul>
<li>Vascular Imaging Devices Market Size analysis for current Market size (2023), and Market forecast for 5 years (2024-2030)</li>
<li>Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years</li>
<li>Key Vascular Imaging Devices Companies dominating the global market.</li>
<li>Various opportunities are available for the other competitor in the Vascular Imaging Devices Market space.</li>
<li>What are the top-performing segments in 2023? How these segments will perform in 2030?</li>
<li>Which are the top-performing regions and countries in the current Market scenario?</li>
<li>Which are the regions and countries where Vascular Imaging Devices Companies should have concentrated on opportunities for Vascular Imaging Devices Market growth in the coming future?</li>
</ul>
<h3>Target Audience who can be benefited from this Vascular Imaging Devices Market Ket Report Study</h3>
<ul>
<li>Vascular Imaging Devices providers</li>
<li>Research organizations and consulting Vascular Imaging Devices Companies</li>
<li>Vascular Imaging Devices-related organizations, associations, forums, and other alliances</li>
<li>Government and corporate offices</li>
<li>Start-up companies, venture capitalists, and private equity firms</li>
<li>Distributors and Traders in Vascular Imaging Devices</li>
<li>Various End-Users want to know more about the Vascular Imaging Devices Market and the latest technological developments in the Vascular Imaging Devices Market.</li>
</ul>
Stay updated with us for Recent Articles @ <a href="https://www.delveinsight.com/blog/">Latest DelveInsight Blogs</a>

1. Vascular Imaging Devices Market Report Introduction
2. Vascular Imaging Devices Market Executive Summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Vascular Imaging Devices Market Key factors analysis
4.1. Vascular Imaging Devices Market Drivers
4.1.1. Growing prevalence of vascular-related diseases in the rising geriatric population
4.1.2. Technological advancements in product development
4.1.3. Increasing adoption rates of minimally invasive surgeries
4.2. Vascular Imaging Devices Market Restraints and Challenges
4.2.1. High cost of equipment
4.2.2. Unavailability of skilled and trained professionals
4.3. Vascular Imaging Devices Market Opportunities
4.3.1. Increasing health awareness in emerging countries
4.3.2. Growing demand for vascular imaging devices in multispeciality and diagnostic care settings
5. Vascular Imaging Devices Porter&rsquo;s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. Vascular Imaging Devices Market layout
6.1. By Type
6.1.1. Minimally Invasive
6.1.1.1. Catheter Angiogram
6.1.1.2. CT Angiography (CTA)
6.1.1.3. Lymphoscintigraphy
6.1.1.4. Venogram
6.1.1.5. Intravascular Ultrasound
6.1.2. Non-Invasive
6.1.2.1. Abdominal Ultrasound
6.1.2.2. Angiography
6.1.2.3. Ankle-Brachial Index (ABI)
6.1.2.4. Captopril Renal Scan
6.1.2.5. Carotid Duplex Ultrasound
6.1.2.6. CT Scan
6.1.2.7. Doppler Ultrasound
6.1.2.8. Duplex Ultrasound
6.1.2.9. Magnetic Resonance Angiography (MRA)
6.1.2.10. Magnetic Resonance Imaging (MRI)
6.2. By Application
6.2.1. Diagnostics
6.2.2. Therapeutics
6.3. By End-User
6.3.1. Hospitals
6.3.2. Diagnostic Imaging Centers
6.3.3. Others
6.4. By Geography
6.4.1. North America Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.1.1. United States Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.1.2. Canada Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.1.3. Mexico Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2. Europe Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.1. France Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.2. Germany Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.3. United Kingdom Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.4. Italy Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.5. Spain Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.2.6. Rest of Europe Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3. Asia-Pacific Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.1. China Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.2. Japan Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.3. India Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.4. Australia Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.5. South Korea Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.3.6. Rest of Asia Pacific Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.4. Rest of the World (RoW) Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.4.1. Middle East Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.4.2. Africa Vascular Imaging Devices Market Size in USD million (2021-2030)
6.4.4.3. South America Vascular Imaging Devices Market Size in USD million (2021-2030)
7. Vascular Imaging Devices Company and Product Profiles
7.1. Siemens Healthcare Limited
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Financial Overview
7.1.4. Product Listing
7.1.5. Entropy
7.2. General Electric Company (GE Healthcare)
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Financial Overview
7.2.4. Product Listing
7.2.5. Entropy
7.3. Koninklijke Philips N.V.
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Financial Overview
7.3.4. Product Listing
7.3.5. Entropy
7.4. FUJIFILM Healthcare
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Financial Overview
7.4.4. Product Listing
7.4.5. Entropy
7.5. Samsung Medison Co., Ltd.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Financial Overview
7.5.4. Product Listing
7.5.5. Entropy
7.6. Shimadzu Corporation
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Financial Overview
7.6.4. Product Listing
7.6.5. Entropy
7.7. Hologic, Inc.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Financial Overview
7.7.4. Product Listing
7.7.5. Entropy
7.8. Abbott Laboratories
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Financial Overview
7.8.4. Product Listing
7.8.5. Entropy
7.9. Carestream Health Inc.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Financial Overview
7.9.4. Product Listing
7.9.5. Entropy
7.10. Toshiba Medical Systems Corporation
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Financial Overview
7.10.4. Product Listing
7.10.5. Entropy
7.11. Terumo Corporation
7.11.1. Company Overview
7.11.2. Company Snapshot
7.11.3. Financial Overview
7.11.4. Product Listing
7.11.5. Entropy
7.12. ESAOTE SPA
7.12.1. Company Overview
7.12.2. Company Snapshot
7.12.3. Financial Overview
7.12.4. Product Listing
7.12.5. Entropy
7.13. Konica Minolta, Inc.
7.13.1. Company Overview
7.13.2. Company Snapshot
7.13.3. Financial Overview
7.13.4. Product Listing
7.13.5. Entropy
7.14. Alpinion Medical Systems Co., Ltd.
7.14.1. Company Overview
7.14.2. Company Snapshot
7.14.3. Financial Overview
7.14.4. Product Listing
7.14.5. Entropy
7.15. Pie Medical Imaging B.V
7.15.1. Company Overview
7.15.2. Company Snapshot
7.15.3. Financial Overview
7.15.4. Product Listing
7.15.5. Entropy
&nbsp;
8. KOL Views
9. Project Approach
10. DelveInsight Capabilities
11. About DelveInsight&nbsp;
12. Disclaimer &amp; Contact Us

Vascular Imaging Devices Market

Vascular Imaging Devices Market Insights, Competitive Landscape, and Market Forecast - 2030

DelveInsight’s ‘Vascular Imaging Devices - Market Insights, Competitive Landscape and Market Forecast - 2030’ report delivers an in-depth understanding of the Vascular Imaging Devices